A detailed history of Steward Financial Group LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Steward Financial Group LLC holds 12 shares of CYTK stock, worth $628. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12
Holding current value
$628
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 20, 2023

BUY
$29.46 - $36.61 $353 - $439
12 New
12 $0
Q1 2023

May 05, 2023

BUY
$33.36 - $45.71 $400 - $548
12 New
12 $0

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.93B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Steward Financial Group LLC Portfolio

Follow Steward Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Financial Group LLC with notifications on news.